Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Successful orthotopic heart transplantation in a patient with Marfan syndrome.

Ogawa Y, Choi CW, Shudo Y, Woo YJ.

J Card Surg. 2019 Jun 24. doi: 10.1111/jocs.14129. [Epub ahead of print]

PMID:
31233233
2.

A gapmer antisense oligonucleotide targeting SRRM4 is a novel therapeutic medicine for lung cancer.

Shimojo M, Kasahara Y, Inoue M, Tsunoda SI, Shudo Y, Kurata T, Obika S.

Sci Rep. 2019 May 20;9(1):7618. doi: 10.1038/s41598-019-43100-1.

3.

Successful Heart-Lung Transplant for a Patient on Continuous-Flow Left Ventricular Assist Device Support Complicated With Amiodarone-Induced Pulmonary Fibrosis.

Currie ME, Shudo Y, Mooney J, Woo YJ.

Transplant Proc. 2019 Mar;51(2):593-594. doi: 10.1016/j.transproceed.2018.12.024. Epub 2019 Jan 3.

PMID:
30879597
4.

Multidisciplinary approach utilizing early, intensive physical rehabilitation to accelerate recovery from veno-venous extracorporeal membrane oxygenation.

Zhu Y, Bankar D, Shudo Y, Woo YJ.

Eur J Cardiothorac Surg. 2019 Feb 22. pii: ezz042. doi: 10.1093/ejcts/ezz042. [Epub ahead of print]

PMID:
30796438
5.

Impact of "increased-risk" donor hearts on transplant outcomes: A propensity-matched analysis.

Shudo Y, Cohen JE, Lingala B, He H, Zhu Y, Woo YJ.

J Thorac Cardiovasc Surg. 2019 Feb;157(2):603-610. doi: 10.1016/j.jtcvs.2018.08.120. Epub 2018 Oct 19.

PMID:
30669225
6.

Cardioaortic replacement for a ruptured root pseudoaneurysm with pulsatile subcutaneous extension.

Wang H, Shudo Y, Hittinger SA, Woo YJ.

Eur J Cardiothorac Surg. 2019 Jan 4. doi: 10.1093/ejcts/ezy447. [Epub ahead of print]

PMID:
30608529
7.

Successful Outcome Following Orthotopic Heart Transplantation With a Donor Half Way Across The Country.

Currie ME, Shudo Y, Woo YJ.

Transplant Proc. 2018 Dec;50(10):4062-4063. doi: 10.1016/j.transproceed.2018.09.014. Epub 2018 Sep 8.

PMID:
30577315
8.

Operative Techniques and Pitfalls in Donor Heart-Lung Procurement.

Salna M, Shudo Y, Woo YJ.

Transplant Proc. 2018 Dec;50(10):3111-3112. doi: 10.1016/j.transproceed.2018.06.009. Epub 2018 Jun 22.

PMID:
30577175
9.

Impact of Donor Obesity on Outcomes After Orthotopic Heart Transplantation.

Shudo Y, Cohen JE, Lingala B, He H, Woo YJ.

J Am Heart Assoc. 2018 Dec 4;7(23):e010253. doi: 10.1161/JAHA.118.010253.

10.

Modulating the Work Function of Graphene by Pulsed Plasma Aided Controlled Chlorination.

Takehira H, Karim MR, Shudo Y, Fukuda M, Mashimo T, Hayami S.

Sci Rep. 2018 Nov 26;8(1):17392. doi: 10.1038/s41598-018-35668-x.

11.

Planned Concomitant Left and Right Ventricular Assist Device Insertion to Avoid Long-term Biventricular Mechanical Support: Bridge to Right Ventricular Recovery.

Salna M, Shudo Y, Teuteberg JJ, Banerjee D, Ha RV, Woo YJ, Hiesinger W.

Heart Surg Forum. 2018 Oct 1;21(5):E412-E414. doi: 10.1532/hsf.2035.

PMID:
30311895
12.

Heart-lung transplantation over the past 10 years: an up-to-date concept.

Shudo Y, Kasinpila P, Lingala B, Kim FY, Woo YJ.

Eur J Cardiothorac Surg. 2019 Feb 1;55(2):304-308. doi: 10.1093/ejcts/ezy253.

PMID:
30260389
13.

An Evaluation of the Behavioral Activation Model of Psychotherapy in a Community Sample in Japan.

Yamamoto T, Hikida I, Shudo Y, Sakai M.

Psychol Rep. 2018 Aug 23:33294118795144. doi: 10.1177/0033294118795144. [Epub ahead of print]

PMID:
30139302
14.

Successful heart-lung-kidney and domino heart transplantation following veno-venous extracorporeal membrane oxygenation support.

Zhu Y, Shudo Y, Lee AM, Woo YJ.

Interact Cardiovasc Thorac Surg. 2019 Feb 1;28(2):316-317. doi: 10.1093/icvts/ivy251.

PMID:
30113636
15.

Reply to Dimarakis and Venkateswaran.

Shudo Y, Wang H, Woo YJ.

Eur J Cardiothorac Surg. 2019 Mar 1;55(3):596. doi: 10.1093/ejcts/ezy280. No abstract available.

PMID:
30113629
16.

Prolonged veno-arterial extracorporeal life support for cardiac failure.

Guenther SP, Shudo Y, Hiesinger W, Banerjee D.

Int J Artif Organs. 2018 Aug;41(8):437-444. doi: 10.1177/0391398818777359. Epub 2018 Jun 13.

PMID:
29896993
17.

Ambulating femoral venoarterial extracorporeal membrane oxygenation bridge to heart-lung transplant.

Shudo Y, Kasinpila P, Lee AM, Rao VK, Woo YJ.

J Thorac Cardiovasc Surg. 2018 Sep;156(3):e135-e137. doi: 10.1016/j.jtcvs.2018.03.002. Epub 2018 Mar 8. No abstract available.

PMID:
29628344
18.

Heart transplant after profoundly extended ambulatory central venoarterial extracorporeal membrane oxygenation.

Shudo Y, Wang H, Ha RV, Hayes AD, Woo YJ.

J Thorac Cardiovasc Surg. 2018 Jul;156(1):e7-e9. doi: 10.1016/j.jtcvs.2018.02.001. Epub 2018 Feb 10. No abstract available.

PMID:
29576264
19.

Beneficial effects of restrictive annuloplasty on subvalvular geometry in patients with functional mitral regurgitation and advanced cardiomyopathy.

Kainuma S, Funatsu T, Kondoh H, Yokota T, Maeda S, Shudo Y, Matsue H, Nishino M, Daimon T, Toda K, Sawa Y, Taniguchi K.

J Thorac Cardiovasc Surg. 2018 Aug;156(2):630-638.e1. doi: 10.1016/j.jtcvs.2017.11.090. Epub 2017 Dec 18.

PMID:
29395191
20.

A modified technique for orthotopic heart transplantation to minimize warm ischaemic time.

Shudo Y, Wang H, Woo YJ.

Eur J Cardiothorac Surg. 2018 May 1;53(5):1089-1090. doi: 10.1093/ejcts/ezx411.

PMID:
29186382
21.

Successful use of donor lungs after repairing severely injured pulmonary vein of donor lungs.

Shudo Y, Miller SL, Boyd JH, Woo YJ.

Eur J Cardiothorac Surg. 2018 Apr 1;53(4):889. doi: 10.1093/ejcts/ezx392. No abstract available.

PMID:
29186381
22.

Percutaneous, minimally invasive approach to implantable left ventricular assist device deactivation.

Kidambi S, Shudo Y, Dake MD, Woo YJ, Ha RV.

J Thorac Cardiovasc Surg. 2018 Feb;155(2):653-654. doi: 10.1016/j.jtcvs.2017.08.120. Epub 2017 Sep 13. No abstract available.

PMID:
29102456
23.

Tissue-engineered smooth muscle cell and endothelial progenitor cell bi-level cell sheets prevent progression of cardiac dysfunction, microvascular dysfunction, and interstitial fibrosis in a rodent model of type 1 diabetes-induced cardiomyopathy.

Kawamura M, Paulsen MJ, Goldstone AB, Shudo Y, Wang H, Steele AN, Stapleton LM, Edwards BB, Eskandari A, Truong VN, Jaatinen KJ, Ingason AB, Miyagawa S, Sawa Y, Woo YJ.

Cardiovasc Diabetol. 2017 Nov 2;16(1):142. doi: 10.1186/s12933-017-0625-4.

24.

Assessing the relationship between quality of life and behavioral activation using the Japanese Behavioral Activation for Depression Scale-Short Form.

Shudo Y, Yamamoto T.

PLoS One. 2017 Sep 28;12(9):e0185221. doi: 10.1371/journal.pone.0185221. eCollection 2017.

25.

A modified explant technique of HeartWare ventricular assist device for bridge to recovery.

Shudo Y, Choi CW, Woo YJ, Ha RV.

Eur J Cardiothorac Surg. 2017 Dec 1;52(6):1223-1224. doi: 10.1093/ejcts/ezx270.

PMID:
28950296
26.

Layered smooth muscle cell-endothelial progenitor cell sheets derived from the bone marrow augment postinfarction ventricular function.

Shudo Y, Goldstone AB, Cohen JE, Patel JB, Hopkins MS, Steele AN, Edwards BB, Kawamura M, Miyagawa S, Sawa Y, Woo YJ.

J Thorac Cardiovasc Surg. 2017 Sep;154(3):955-963. doi: 10.1016/j.jtcvs.2017.04.081. Epub 2017 May 24.

27.

An innovative biologic system for photon-powered myocardium in the ischemic heart.

Cohen JE, Goldstone AB, Paulsen MJ, Shudo Y, Steele AN, Edwards BB, Patel JB, MacArthur JW Jr, Hopkins MS, Burnett CE, Jaatinen KJ, Thakore AD, Farry JM, Truong VN, Bourdillon AT, Stapleton LM, Eskandari A, Fairman AS, Hiesinger W, Esipova TV, Patrick WL, Ji K, Shizuru JA, Woo YJ.

Sci Adv. 2017 Jun 14;3(6):e1603078. doi: 10.1126/sciadv.1603078. eCollection 2017 Jun.

28.

Gene expression profiling of acute type A aortic dissection combined with in vitro assessment.

Kimura N, Futamura K, Arakawa M, Okada N, Emrich F, Okamura H, Sato T, Shudo Y, Koyano TK, Yamaguchi A, Adachi H, Matsuda A, Kawahito K, Matsumoto K, Fischbein MP.

Eur J Cardiothorac Surg. 2017 Oct 1;52(4):810-817. doi: 10.1093/ejcts/ezx095.

PMID:
28402522
29.

Current status of domino heart transplantation.

Shudo Y, Ma M, Boyd JH, Woo YJ.

J Card Surg. 2017 Mar;32(3):229-232. doi: 10.1111/jocs.13104. Epub 2017 Feb 20. Review.

PMID:
28219115
30.

Adipose tissue-derived multi-lineage progenitor cells improve left ventricular dysfunction in porcine ischemic cardiomyopathy model.

Shudo Y, Miyagawa S, Ohkura H, Fukushima S, Saito A, Kawaguchi N, Matsuura N, Toda K, Sakaguchi T, Nishi H, Yoshikawa Y, Shimizu T, Okano T, Matsuyama A, Sawa Y.

J Heart Lung Transplant. 2017 Feb;36(2):237-239. doi: 10.1016/j.healun.2016.11.012. Epub 2016 Dec 6. No abstract available.

PMID:
28159019
31.

Operative technique and pitfalls in donor heart procurement.

Shudo Y, Hiesinger W, Oyer PE, Woo YJ.

Asian Cardiovasc Thorac Ann. 2017 Jan;25(1):80-82. doi: 10.1177/0218492316678716. Epub 2016 Nov 12.

PMID:
28074702
32.

Longitudinal Predictions of Depression Symptoms Using the Activation and Avoidance Subscales of the Japanese Behavioral Activation for Depression Scale-Short Form.

Shudo Y, Yamamoto T, Sakai M.

Psychol Rep. 2017 Feb;120(1):130-140. doi: 10.1177/0033294116680794. Epub 2016 Nov 25.

PMID:
27887002
33.

A modified implantation technique of left ventricular assist device: optimal outflow tract positioning.

Shudo Y, Choi CW, Woo YJ, Ha RV.

Int J Cardiol. 2016 Nov 15;223:776-778. doi: 10.1016/j.ijcard.2016.08.209. Epub 2016 Aug 27. No abstract available.

PMID:
27573606
34.

Isolation and trans-differentiation of mesenchymal stromal cells into smooth muscle cells: Utility and applicability for cell-sheet engineering.

Shudo Y, Cohen JE, Goldstone AB, MacArthur JW, Patel J, Edwards BB, Hopkins MS, Steele AN, Joubert LM, Miyagawa S, Sawa Y, Woo YJ.

Cytotherapy. 2016 Apr;18(4):510-7. doi: 10.1016/j.jcyt.2016.01.012.

35.

Pituitary adenylate cyclase-activating polypeptide is regulated by alternative splicing of transcriptional repressor REST/NRSF in nerve injury.

Shudo Y, Shimojo M, Fukunaga M, Ito S.

Life Sci. 2015 Dec 15;143:174-81. doi: 10.1016/j.lfs.2015.10.033. Epub 2015 Oct 27.

PMID:
26518165
36.

A Tissue-Engineered Chondrocyte Cell Sheet Induces Extracellular Matrix Modification to Enhance Ventricular Biomechanics and Attenuate Myocardial Stiffness in Ischemic Cardiomyopathy.

Shudo Y, Cohen JE, MacArthur JW, Goldstone AB, Otsuru S, Trubelja A, Patel J, Edwards BB, Hung G, Fairman AS, Brusalis C, Hiesinger W, Atluri P, Hiraoka A, Miyagawa S, Sawa Y, Woo YJ.

Tissue Eng Part A. 2015 Oct;21(19-20):2515-25. doi: 10.1089/ten.TEA.2014.0155. Epub 2015 Sep 18.

37.

B-type natriuretic peptide response and reverse left ventricular remodeling after surgical correction of functional mitral regurgitation in patients with advanced cardiomyopathy.

Kainuma S, Taniguchi K, Toda K, Shudo Y, Takeda K, Funatsu T, Miyagawa S, Kondoh H, Nishi H, Yoshikawa Y, Fukushima S, Hamada S, Kubo K, Daimon T, Sawa Y.

J Cardiol. 2015 Oct;66(4):279-85. doi: 10.1016/j.jjcc.2015.02.015. Epub 2015 Apr 4.

38.

Non-resectional leaflet remodeling mitral valve repair preserves leaflet mobility: A quantitative echocardiographic analysis of mitral valve configuration.

Shudo Y, Cohen JE, MacArthur JW, Goldstone AB, Hiraoka A, Howard J, Fairman AS, Patel J, Edwards BB, Atluri P, Woo YJ.

Int J Cardiol. 2015;186:16-8. doi: 10.1016/j.ijcard.2015.03.239. Epub 2015 Mar 18. No abstract available.

PMID:
25804458
39.

Evaluation of late aortic insufficiency with continuous flow left ventricular assist device†.

Hiraoka A, Cohen JE, Shudo Y, MacArthur JW Jr, Howard JL, Fairman AS, Atluri P, Kirkpatrick JN, Woo YJ.

Eur J Cardiothorac Surg. 2015 Sep;48(3):400-6. doi: 10.1093/ejcts/ezu507. Epub 2015 Feb 3.

PMID:
25653250
40.

Analog study investigating diary assessments of rewards and punishments for emotional states.

Yamamoto T, Shudo Y, Sakai M.

Psychol Rep. 2014 Dec;115(3):842-8. doi: 10.2466/02.15.PR0.115c34z2.

PMID:
25539172
41.

A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathy.

Cohen JE, Purcell BP, MacArthur JW Jr, Mu A, Shudo Y, Patel JB, Brusalis CM, Trubelja A, Fairman AS, Edwards BB, Davis MS, Hung G, Hiesinger W, Atluri P, Margulies KB, Burdick JA, Woo YJ.

Circ Heart Fail. 2014 Jul;7(4):619-26. doi: 10.1161/CIRCHEARTFAILURE.113.001273. Epub 2014 Jun 5.

42.

Bioengineered stromal cell-derived factor-1α analogue delivered as an angiogenic therapy significantly restores viscoelastic material properties of infarcted cardiac muscle.

Trubelja A, MacArthur JW, Sarver JJ, Cohen JE, Hung G, Shudo Y, Fairman AS, Patel J, Edwards BB, Damrauer SM, Hiesinger W, Atluri P, Woo YJ.

J Biomech Eng. 2014 Aug;136(8). doi: 10.1115/1.4027731.

43.

Preclinical evaluation of the engineered stem cell chemokine stromal cell-derived factor 1α analog in a translational ovine myocardial infarction model.

Macarthur JW Jr, Cohen JE, McGarvey JR, Shudo Y, Patel JB, Trubelja A, Fairman AS, Edwards BB, Hung G, Hiesinger W, Goldstone AB, Atluri P, Wilensky RL, Pilla JJ, Gorman JH 3rd, Gorman RC, Woo YJ.

Circ Res. 2014 Feb 14;114(4):650-9. doi: 10.1161/CIRCRESAHA.114.302884. Epub 2013 Dec 23.

44.

Addition of mesenchymal stem cells enhances the therapeutic effects of skeletal myoblast cell-sheet transplantation in a rat ischemic cardiomyopathy model.

Shudo Y, Miyagawa S, Ohkura H, Fukushima S, Saito A, Shiozaki M, Kawaguchi N, Matsuura N, Shimizu T, Okano T, Matsuyama A, Sawa Y.

Tissue Eng Part A. 2014 Feb;20(3-4):728-39. doi: 10.1089/ten.TEA.2012.0534. Epub 2014 Jan 3.

45.

Continuous flow left ventricular assist device implant significantly improves pulmonary hypertension, right ventricular contractility, and tricuspid valve competence.

Atluri P, Fairman AS, MacArthur JW, Goldstone AB, Cohen JE, Howard JL, Zalewski CM, Shudo Y, Woo YJ.

J Card Surg. 2013 Nov;28(6):770-5. doi: 10.1111/jocs.12214. Epub 2013 Sep 30.

46.

Normalization of postinfarct biomechanics using a novel tissue-engineered angiogenic construct.

Atluri P, Trubelja A, Fairman AS, Hsiao P, MacArthur JW, Cohen JE, Shudo Y, Frederick JR, Woo YJ.

Circulation. 2013 Sep 10;128(11 Suppl 1):S95-104. doi: 10.1161/CIRCULATIONAHA.112.000368.

47.

Sustained release of engineered stromal cell-derived factor 1-α from injectable hydrogels effectively recruits endothelial progenitor cells and preserves ventricular function after myocardial infarction.

MacArthur JW Jr, Purcell BP, Shudo Y, Cohen JE, Fairman A, Trubelja A, Patel J, Hsiao P, Yang E, Lloyd K, Hiesinger W, Atluri P, Burdick JA, Woo YJ.

Circulation. 2013 Sep 10;128(11 Suppl 1):S79-86. doi: 10.1161/CIRCULATIONAHA.112.000343.

48.

Spatially oriented, temporally sequential smooth muscle cell-endothelial progenitor cell bi-level cell sheet neovascularizes ischemic myocardium.

Shudo Y, Cohen JE, Macarthur JW, Atluri P, Hsiao PF, Yang EC, Fairman AS, Trubelja A, Patel J, Miyagawa S, Sawa Y, Woo YJ.

Circulation. 2013 Sep 10;128(11 Suppl 1):S59-68. doi: 10.1161/CIRCULATIONAHA.112.000293.

49.

The small cell lung cancer-specific isoform of RE1-silencing transcription factor (REST) is regulated by neural-specific Ser/Arg repeat-related protein of 100 kDa (nSR100).

Shimojo M, Shudo Y, Ikeda M, Kobashi T, Ito S.

Mol Cancer Res. 2013 Oct;11(10):1258-68. doi: 10.1158/1541-7786.MCR-13-0269. Epub 2013 Aug 8.

50.

Predicting right ventricular failure in the modern, continuous flow left ventricular assist device era.

Atluri P, Goldstone AB, Fairman AS, MacArthur JW, Shudo Y, Cohen JE, Acker AL, Hiesinger W, Howard JL, Acker MA, Woo YJ.

Ann Thorac Surg. 2013 Sep;96(3):857-63; discussion 863-4. doi: 10.1016/j.athoracsur.2013.03.099. Epub 2013 Jun 21.

Supplemental Content

Support Center